Back
CRISPR Therapeutics AG Stock Predictions
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
44
CRSP
CRISPR Therapeutics AG
Last Price:
49.70
Seasonality Move:
3.26%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock marketCRISPR Therapeutics AG Stock Forecast
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 28.9% based on the past 7 years of stock performance.
- CRISPR Therapeutics AG has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is CRISPR Therapeutics AG Stock Undervalued?
The current CRISPR Therapeutics AG [CRSP] share price is $49.55. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal. - CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 28.9% based on the past 7 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
- CRISPR Therapeutics AG has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
91.10
52-Week Low:
37.55
Prediction Charts
Market Cap:
4.22B
Price in USD:
49.55
Volume:
1.53M
Beta:
1.99
Technical Analysis
SMA50:
50.94
SMA100:
53.68
SMA200:
60.86
52-Wk Change:
4.01%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?
Yes, CRISPR Therapeutics AG is a publicly traded company. -
What is the CRISPR Therapeutics AG stock quote today?
The CRISPR Therapeutics AG stock price is 49.55 USD today. -
How to buy CRISPR Therapeutics AG stock online?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 47.80 | 47.55 | 48.71 | 47.45 |
| Aug-30 | 47.72 | 47.72 | 48.18 | 47.00 |
| Sep-3 | 47.37 | 45.51 | 48.27 | 45.19 |
| Sep-4 | 45.39 | 45.03 | 46.14 | 44.71 |
| Sep-5 | 45.17 | 45.29 | 45.73 | 44.04 |
| Sep-6 | 45.25 | 44.62 | 45.60 | 43.42 |
| Sep-9 | 44.71 | 44.83 | 45.57 | 44.38 |
| Sep-10 | 45.00 | 45.59 | 45.81 | 44.14 |
| Sep-11 | 45.23 | 45.46 | 45.50 | 44.21 |
| Sep-12 | 45.36 | 45.94 | 46.36 | 44.43 |
| Sep-13 | 46.50 | 48.94 | 48.99 | 46.45 |
| Sep-16 | 48.97 | 47.74 | 49.09 | 47.05 |
| Sep-17 | 48.26 | 49.87 | 50.61 | 48.07 |
| Sep-18 | 50.00 | 49.55 | 51.99 | 49.18 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.01 per share, a decrease this year of $2.74 per share, and an increase next year of $0.41 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.